Maria Cecilia Querido de Oliveira1,2, Beatriz Nascimento F Lebre Martins1, Alan Roger Santos-Silva1, César Rivera3, Pablo Agustin Vargas1, Márcio Ajudarte Lopes1, Aljomar Jose Vechiato-Filho2, Thaís Bianca Brandão4, Ana Carolina Prado-Ribeiro5,6. 1. Oral Diagnosis Department, Piracicaba Dental School, UNICAMP, Piracicaba, Brazil. 2. Serviço de Odontologia Oncológica, Instituto do Câncer do Estado de São Paulo, ICESP-FMUSP, Faculdade de Medicina da Universidade de São Paulo, Av. Doutor Arnaldo, 251 Cerqueira César, São Paulo, CEP 01246-000, Brazil. 3. Department of Basic Biomedical Sciences, Universidad de Talca, Talca, Chile. 4. Odontologia Oncológica D'or, São Paulo, Brazil. 5. Oral Diagnosis Department, Piracicaba Dental School, UNICAMP, Piracicaba, Brazil. carol_pr@yahoo.com.br. 6. Serviço de Odontologia Oncológica, Instituto do Câncer do Estado de São Paulo, ICESP-FMUSP, Faculdade de Medicina da Universidade de São Paulo, Av. Doutor Arnaldo, 251 Cerqueira César, São Paulo, CEP 01246-000, Brazil. carol_pr@yahoo.com.br.
Abstract
PURPOSE: The objectives of this study were to describe the distribution and the clinicopathological features of the most common causes for dental treatment needs during the hospitalization of cancer patients. METHODS: A retrospective cohort study of 2664 hospitalized cancer patients that analyzed the main dental treatment needs and dental procedures performed from January 2010 to December 2017. RESULTS: A total of 2664 medical patients were included in this study. Non-Hodgkin lymphoma (17.2%) was the most common cancer type, followed by leukemia (14.8%), and oral and oropharyngeal squamous cell carcinoma (10.5%). The most common reasons for patients' hospitalization were chemotherapy protocols (18.8%), monitoring head and neck surgeries (9.7%), and febrile neutropenia (9.6%). The main motivation for the medical team to request dental evaluation was oral mucositis (22.8%) followed by oral pain or toothache (10.8%) and fungal, viral oral infections or traumatic oral lesions (9.9%). The dental treatment needs most observed were pain due to oral mucositis (17%), dental treatment prior to radiotherapy (RT), chemotherapy (CT) or bisphosphonate therapy (BP) (10.8%), teeth extractions (6.5%), and prophylactic photobiomodulation therapy (6.3%), whereas the most common dental treatments performed were oral hygiene protocols (30.2%), photobiomodulation therapy (prophylactic and curative) (21.7%), and dental treatment prior to cancer treatment initiation (RT, CT, and BP) (9.5%). CONCLUSION: This study can be considered original in the oncologic context, providing new information about the most frequent dental treatment needs among a large population of hospitalized cancer patients.
PURPOSE: The objectives of this study were to describe the distribution and the clinicopathological features of the most common causes for dental treatment needs during the hospitalization of cancerpatients. METHODS: A retrospective cohort study of 2664 hospitalized cancerpatients that analyzed the main dental treatment needs and dental procedures performed from January 2010 to December 2017. RESULTS: A total of 2664 medical patients were included in this study. Non-Hodgkin lymphoma (17.2%) was the most common cancer type, followed by leukemia (14.8%), and oral and oropharyngeal squamous cell carcinoma (10.5%). The most common reasons for patients' hospitalization were chemotherapy protocols (18.8%), monitoring head and neck surgeries (9.7%), and febrile neutropenia (9.6%). The main motivation for the medical team to request dental evaluation was oral mucositis (22.8%) followed by oral pain or toothache (10.8%) and fungal, viral oral infections or traumatic oral lesions (9.9%). The dental treatment needs most observed were pain due to oral mucositis (17%), dental treatment prior to radiotherapy (RT), chemotherapy (CT) or bisphosphonate therapy (BP) (10.8%), teeth extractions (6.5%), and prophylactic photobiomodulation therapy (6.3%), whereas the most common dental treatments performed were oral hygiene protocols (30.2%), photobiomodulation therapy (prophylactic and curative) (21.7%), and dental treatment prior to cancer treatment initiation (RT, CT, and BP) (9.5%). CONCLUSION: This study can be considered original in the oncologic context, providing new information about the most frequent dental treatment needs among a large population of hospitalized cancerpatients.
Authors: Paula Maria Maracajá Bezerra; Thiago Isidro Vieira; Fabio Gomes Dos Santos; Isabella Lima Arrais Ribeiro; Simone Alves de Sousa; Ana Maria Gondim Valença Journal: Support Care Cancer Date: 2022-08-01 Impact factor: 3.359
Authors: Paula Maria Maracajá Bezerra; Maria Eduarda Alves Sampaio; Fabio Gomes Dos Santos; Isabella Lima Arrais Ribeiro; Bianca Marques Santiago; Simone Alves de Sousa; Ana Maria Gondim Valença Journal: Support Care Cancer Date: 2021-06-29 Impact factor: 3.603